Lifeboat Foundation

The University of Chicago Medicine is among the first 30 institutions in the country to offer tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, immediately activating as an authorized treatment center after federal regulators approved the treatment on February 16, 2024.

TILs are…

Some patients with advanced melanomas — those that can’t be surgically removed or have spread to other parts of the body — don’t respond to standard treatment options such as immunotherapies and targeted therapies. TIL therapy gives these patients another therapeutic option: a completely personalized treatment made from the patient’s own cells that needs to be administered only once, since the cells remain in the body and keep performing their tumor-attacking duties.

Continue reading “UChicago Medicine to offer TIL therapy for advanced melanoma” »

During a sunny morning on Florida’s Gulf Coast last month, an 11-year-old golden retriever named Hunter bounded through a pine grove.

A Yale researcher developed a vaccine that can slow or halt certain cancers in dogs. And it could be used to treat humans in the future.

Continue reading “Novel cancer vaccine offers new hope for dogs — and those who love them” »

Microsoft presents LLMs in the Imaginarium.

Tool Learning through Simulated Trial and Error https://huggingface.co/papers/2403.

Tools are essential for large language models (LLMs) to acquire up-to-date information and take consequential actions in external environments.

Continue reading “LLMs in the Imaginarium: Tool Learning through Simulated Trial and Error” »

Shared with Dropbox.

The April 8 eclipse is expected to bring an increase in traffic to Central Texas.

Ocean-going vessels with no-one on board — a vision of the future that’s coming faster you think.

And that’s a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.

The first was to continue with a legacy vendor. Three companies — Dominion, ES&S, and Hart InterCivic — control roughly 90 percent of the U.S. voting technology market. All three are privately held, meaning they’re required to reveal little about their financial workings and they’re also committed to keeping their source code from becoming fully public.

The second future was to gamble on VotingWorks, a nonprofit with only 17 employees and voting machine contracts in just five small counties, all in Mississippi. The company has taken the opposite approach to the Big Three. Its financial statements are posted on its website, and every line of code powering its machines is published on GitHub, available for anyone to inspect.

Shared with Dropbox.